MSD will certainly not exercise its choice on the Danish firm’s gonorrhea injection prospect, indicating that Evaxion will certainly need to wait a very long time for prospective turning point settlements of as much as practically USD 600m.
发布者:BY ALBERT RONNING-ANDERSSON,转转请注明出处:https://robotalks.cn/evaxion-ceo-calls-msd-rejection-disappointing-unfortunate-and-surprising/